table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Kidney Cancer Drug Market Size Analysis from 2023 to 2028
1.5.1 Global Kidney Cancer Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Kidney Cancer Drug Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Kidney Cancer Drug Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Kidney Cancer Drug Industry Impact
Chapter 2 Global Kidney Cancer Drug Competition by Types, Applications, and Top Regions and Countries
2.1 Global Kidney Cancer Drug (Volume and Value) by Type
2.1.1 Global Kidney Cancer Drug Consumption and Market Share by Type (2017-2022)
2.1.2 Global Kidney Cancer Drug Revenue and Market Share by Type (2017-2022)
2.2 Global Kidney Cancer Drug (Volume and Value) by Application
2.2.1 Global Kidney Cancer Drug Consumption and Market Share by Application (2017-2022)
2.2.2 Global Kidney Cancer Drug Revenue and Market Share by Application (2017-2022)
2.3 Global Kidney Cancer Drug (Volume and Value) by Regions
2.3.1 Global Kidney Cancer Drug Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Kidney Cancer Drug Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Kidney Cancer Drug Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Kidney Cancer Drug Consumption by Regions (2017-2022)
4.2 North America Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
4.10 South America Kidney Cancer Drug Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Kidney Cancer Drug Market Analysis
5.1 North America Kidney Cancer Drug Consumption and Value Analysis
5.1.1 North America Kidney Cancer Drug Market Under COVID-19
5.2 North America Kidney Cancer Drug Consumption Volume by Types
5.3 North America Kidney Cancer Drug Consumption Structure by Application
5.4 North America Kidney Cancer Drug Consumption by Top Countries
5.4.1 United States Kidney Cancer Drug Consumption Volume from 2017 to 2022
5.4.2 Canada Kidney Cancer Drug Consumption Volume from 2017 to 2022
5.4.3 Mexico Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 6 East Asia Kidney Cancer Drug Market Analysis
6.1 East Asia Kidney Cancer Drug Consumption and Value Analysis
6.1.1 East Asia Kidney Cancer Drug Market Under COVID-19
6.2 East Asia Kidney Cancer Drug Consumption Volume by Types
6.3 East Asia Kidney Cancer Drug Consumption Structure by Application
6.4 East Asia Kidney Cancer Drug Consumption by Top Countries
6.4.1 China Kidney Cancer Drug Consumption Volume from 2017 to 2022
6.4.2 Japan Kidney Cancer Drug Consumption Volume from 2017 to 2022
6.4.3 South Korea Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 7 Europe Kidney Cancer Drug Market Analysis
7.1 Europe Kidney Cancer Drug Consumption and Value Analysis
7.1.1 Europe Kidney Cancer Drug Market Under COVID-19
7.2 Europe Kidney Cancer Drug Consumption Volume by Types
7.3 Europe Kidney Cancer Drug Consumption Structure by Application
7.4 Europe Kidney Cancer Drug Consumption by Top Countries
7.4.1 Germany Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.2 UK Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.3 France Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.4 Italy Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.5 Russia Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.6 Spain Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.7 Netherlands Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.8 Switzerland Kidney Cancer Drug Consumption Volume from 2017 to 2022
7.4.9 Poland Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 8 South Asia Kidney Cancer Drug Market Analysis
8.1 South Asia Kidney Cancer Drug Consumption and Value Analysis
8.1.1 South Asia Kidney Cancer Drug Market Under COVID-19
8.2 South Asia Kidney Cancer Drug Consumption Volume by Types
8.3 South Asia Kidney Cancer Drug Consumption Structure by Application
8.4 South Asia Kidney Cancer Drug Consumption by Top Countries
8.4.1 India Kidney Cancer Drug Consumption Volume from 2017 to 2022
8.4.2 Pakistan Kidney Cancer Drug Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Kidney Cancer Drug Market Analysis
9.1 Southeast Asia Kidney Cancer Drug Consumption and Value Analysis
9.1.1 Southeast Asia Kidney Cancer Drug Market Under COVID-19
9.2 Southeast Asia Kidney Cancer Drug Consumption Volume by Types
9.3 Southeast Asia Kidney Cancer Drug Consumption Structure by Application
9.4 Southeast Asia Kidney Cancer Drug Consumption by Top Countries
9.4.1 Indonesia Kidney Cancer Drug Consumption Volume from 2017 to 2022
9.4.2 Thailand Kidney Cancer Drug Consumption Volume from 2017 to 2022
9.4.3 Singapore Kidney Cancer Drug Consumption Volume from 2017 to 2022
9.4.4 Malaysia Kidney Cancer Drug Consumption Volume from 2017 to 2022
9.4.5 Philippines Kidney Cancer Drug Consumption Volume from 2017 to 2022
9.4.6 Vietnam Kidney Cancer Drug Consumption Volume from 2017 to 2022
9.4.7 Myanmar Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 10 Middle East Kidney Cancer Drug Market Analysis
10.1 Middle East Kidney Cancer Drug Consumption and Value Analysis
10.1.1 Middle East Kidney Cancer Drug Market Under COVID-19
10.2 Middle East Kidney Cancer Drug Consumption Volume by Types
10.3 Middle East Kidney Cancer Drug Consumption Structure by Application
10.4 Middle East Kidney Cancer Drug Consumption by Top Countries
10.4.1 Turkey Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.3 Iran Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.5 Israel Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.6 Iraq Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.7 Qatar Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.8 Kuwait Kidney Cancer Drug Consumption Volume from 2017 to 2022
10.4.9 Oman Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 11 Africa Kidney Cancer Drug Market Analysis
11.1 Africa Kidney Cancer Drug Consumption and Value Analysis
11.1.1 Africa Kidney Cancer Drug Market Under COVID-19
11.2 Africa Kidney Cancer Drug Consumption Volume by Types
11.3 Africa Kidney Cancer Drug Consumption Structure by Application
11.4 Africa Kidney Cancer Drug Consumption by Top Countries
11.4.1 Nigeria Kidney Cancer Drug Consumption Volume from 2017 to 2022
11.4.2 South Africa Kidney Cancer Drug Consumption Volume from 2017 to 2022
11.4.3 Egypt Kidney Cancer Drug Consumption Volume from 2017 to 2022
11.4.4 Algeria Kidney Cancer Drug Consumption Volume from 2017 to 2022
11.4.5 Morocco Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 12 Oceania Kidney Cancer Drug Market Analysis
12.1 Oceania Kidney Cancer Drug Consumption and Value Analysis
12.2 Oceania Kidney Cancer Drug Consumption Volume by Types
12.3 Oceania Kidney Cancer Drug Consumption Structure by Application
12.4 Oceania Kidney Cancer Drug Consumption by Top Countries
12.4.1 Australia Kidney Cancer Drug Consumption Volume from 2017 to 2022
12.4.2 New Zealand Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 13 South America Kidney Cancer Drug Market Analysis
13.1 South America Kidney Cancer Drug Consumption and Value Analysis
13.1.1 South America Kidney Cancer Drug Market Under COVID-19
13.2 South America Kidney Cancer Drug Consumption Volume by Types
13.3 South America Kidney Cancer Drug Consumption Structure by Application
13.4 South America Kidney Cancer Drug Consumption Volume by Major Countries
13.4.1 Brazil Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.2 Argentina Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.3 Columbia Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.4 Chile Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.5 Venezuela Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.6 Peru Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Kidney Cancer Drug Consumption Volume from 2017 to 2022
13.4.8 Ecuador Kidney Cancer Drug Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Kidney Cancer Drug Business
14.1 Active Biotech
14.1.1 Active Biotech Company Profile
14.1.2 Active Biotech Kidney Cancer Drug Product Specification
14.1.3 Active Biotech Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Amgen
14.2.1 Amgen Company Profile
14.2.2 Amgen Kidney Cancer Drug Product Specification
14.2.3 Amgen Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bayer AG
14.3.1 Bayer AG Company Profile
14.3.2 Bayer AG Kidney Cancer Drug Product Specification
14.3.3 Bayer AG Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Cipla Limited
14.4.1 Cipla Limited Company Profile
14.4.2 Cipla Limited Kidney Cancer Drug Product Specification
14.4.3 Cipla Limited Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 F. Hoffmann-La Roche
14.5.1 F. Hoffmann-La Roche Company Profile
14.5.2 F. Hoffmann-La Roche Kidney Cancer Drug Product Specification
14.5.3 F. Hoffmann-La Roche Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Genentech
14.6.1 Genentech Company Profile
14.6.2 Genentech Kidney Cancer Drug Product Specification
14.6.3 Genentech Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Glaxosmithkline PLC
14.7.1 Glaxosmithkline PLC Company Profile
14.7.2 Glaxosmithkline PLC Kidney Cancer Drug Product Specification
14.7.3 Glaxosmithkline PLC Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Novartis AG
14.8.1 Novartis AG Company Profile
14.8.2 Novartis AG Kidney Cancer Drug Product Specification
14.8.3 Novartis AG Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Onyx Pharmaceuticals
14.9.1 Onyx Pharmaceuticals Company Profile
14.9.2 Onyx Pharmaceuticals Kidney Cancer Drug Product Specification
14.9.3 Onyx Pharmaceuticals Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Pfizer
14.10.1 Pfizer Company Profile
14.10.2 Pfizer Kidney Cancer Drug Product Specification
14.10.3 Pfizer Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Abbott Laboratories
14.11.1 Abbott Laboratories Company Profile
14.11.2 Abbott Laboratories Kidney Cancer Drug Product Specification
14.11.3 Abbott Laboratories Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Aveo Pharmaceuticals
14.12.1 Aveo Pharmaceuticals Company Profile
14.12.2 Aveo Pharmaceuticals Kidney Cancer Drug Product Specification
14.12.3 Aveo Pharmaceuticals Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Immatics Biotechnologies
14.13.1 Immatics Biotechnologies Company Profile
14.13.2 Immatics Biotechnologies Kidney Cancer Drug Product Specification
14.13.3 Immatics Biotechnologies Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Prometheus Laboratories
14.14.1 Prometheus Laboratories Company Profile
14.14.2 Prometheus Laboratories Kidney Cancer Drug Product Specification
14.14.3 Prometheus Laboratories Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Exelixis
14.15.1 Exelixis Company Profile
14.15.2 Exelixis Kidney Cancer Drug Product Specification
14.15.3 Exelixis Kidney Cancer Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Kidney Cancer Drug Market Forecast (2023-2028)
15.1 Global Kidney Cancer Drug Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Kidney Cancer Drug Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Kidney Cancer Drug Value and Growth Rate Forecast (2023-2028)
15.2 Global Kidney Cancer Drug Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Kidney Cancer Drug Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Kidney Cancer Drug Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Kidney Cancer Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Kidney Cancer Drug Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Kidney Cancer Drug Consumption Forecast by Type (2023-2028)
15.3.2 Global Kidney Cancer Drug Revenue Forecast by Type (2023-2028)
15.3.3 Global Kidney Cancer Drug Price Forecast by Type (2023-2028)
15.4 Global Kidney Cancer Drug Consumption Volume Forecast by Application (2023-2028)
15.5 Kidney Cancer Drug Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
